These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30455635)

  • 1. P7C3 Inhibits LPS-Induced Microglial Activation to Protect Dopaminergic Neurons Against Inflammatory Factor-Induced Cell Death
    Gu C; Hu Q; Wu J; Mu C; Ren H; Liu CF; Wang G
    Front Cell Neurosci; 2018; 12():400. PubMed ID: 30455635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo.
    Gu C; Zhang Y; Hu Q; Wu J; Ren H; Liu CF; Wang G
    Cell Death Dis; 2017 Jun; 8(6):e2858. PubMed ID: 28569794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Z-guggulsterone negatively controls microglia-mediated neuroinflammation via blocking IκB-α-NF-κB signals.
    Huang C; Wang J; Lu X; Hu W; Wu F; Jiang B; Ling Y; Yang R; Zhang W
    Neurosci Lett; 2016 Apr; 619():34-42. PubMed ID: 26879835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
    Gu C; Wang F; Zhang YT; Wei SZ; Liu JY; Sun HY; Wang GH; Liu CF
    Aging Cell; 2021 Jun; 20(6):e13375. PubMed ID: 33964119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway.
    Guo DK; Zhu Y; Sun HY; Xu XY; Zhang S; Hao ZB; Wang GH; Mu CC; Ren HG
    Acta Pharmacol Sin; 2019 Jan; 40(1):26-34. PubMed ID: 29950615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65.
    Lin Z; Chen C; Yang D; Ding J; Wang G; Ren H
    Cell Death Dis; 2021 Jul; 12(8):715. PubMed ID: 34274951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P7C3 suppresses astrocytic senescence to protect dopaminergic neurons: Implication in the mouse model of Parkinson's disease.
    Chen Y; Zhu Z; Yan Y; Sun H; Wang G; Du X; Li F; Yuan S; Wang W; Wang M; Gu C
    CNS Neurosci Ther; 2024 Jul; 30(7):e14819. PubMed ID: 39056208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons.
    Shen W; Qi R; Zhang J; Wang Z; Wang H; Hu C; Zhao Y; Bie M; Wang Y; Fu Y; Chen M; Lu D
    Brain Res Bull; 2012 Aug; 88(5):487-94. PubMed ID: 22580132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-κB signalling pathway in Parkinson's disease model.
    Gan P; Xia Q; Hang G; Zhou Y; Qian X; Wang X; Ding L
    Clin Exp Pharmacol Physiol; 2019 Apr; 46(4):337-349. PubMed ID: 30485484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.
    Sharma M; Flood PM
    J Neuroimmunol; 2018 Dec; 325():10-19. PubMed ID: 30352316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways.
    Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J
    Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.